These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30334604)

  • 1. Strengthening stakeholder engagement through ethics review in biomedical HIV prevention trials: opportunities and complexities.
    Slack C; Wilkinson A; Salzwedel J; Ndebele P
    J Int AIDS Soc; 2018 Oct; 21 Suppl 7(Suppl Suppl 7):e25172. PubMed ID: 30334604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "
    Wilkinson A; Slack C; Thabethe S; Salzwedel J
    J Empir Res Hum Res Ethics; 2022 Jul; 17(3):292-303. PubMed ID: 35164594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.
    Day S; Blumberg M; Vu T; Zhao Y; Rennie S; Tucker JD
    J Int AIDS Soc; 2018 Oct; 21 Suppl 7(Suppl Suppl 7):e25174. PubMed ID: 30334358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study.
    Newman PA; Rubincam C; Slack C; Essack Z; Chakrapani V; Chuang DM; Tepjan S; Shunmugam M; Roungprakhon S; Logie C; Koen J; Lindegger G
    PLoS One; 2015; 10(8):e0135937. PubMed ID: 26295159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifts in UNAIDS ethics guidance and implications for ethics review of preventive HIV vaccine trials.
    Slack C; Ndebele P; Allen M; Salzwedel J
    J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25796. PubMed ID: 34806302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence.
    Newman PA; Rubincam C
    Expert Rev Vaccines; 2014 Dec; 13(12):1553-62. PubMed ID: 25174764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "3 Ps" of EmPowerment, Partnership and Protection - Stakeholder Perceptions of Beneficial Outcomes of Engagement in HIV Prevention Trials.
    Wilkinson A; Thabethe S; Salzwedel J; Slack C
    J Empir Res Hum Res Ethics; 2024 Feb; 19(1-2):37-47. PubMed ID: 38105464
    [No Abstract]   [Full Text] [Related]  

  • 8. Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub-Saharan Africa.
    Baron D; Essien T; Pato S; Magongo M; Mbandazayo N; Scorgie F; Rees H; Delany-Moretlwe S
    J Int AIDS Soc; 2018 Oct; 21 Suppl 7(Suppl Suppl 7):e25175. PubMed ID: 30334610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethical challenges and opportunities of implementing engagement strategies in health research.
    Salerno J; Coleman KJ; Jones F; Peters ES
    Ann Epidemiol; 2021 Jul; 59():37-43. PubMed ID: 33894383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond clinical trials: social outcomes of structured stakeholder engagement in biomedical HIV prevention trials in China.
    Liu C; Meyers K
    Cult Health Sex; 2020 Dec; 22(12):1365-1381. PubMed ID: 31702447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. South African Research Ethics Committee Review of Standards of Prevention in HIV Vaccine Trial Protocols.
    Essack Z; Wassenaar DR
    J Empir Res Hum Res Ethics; 2018 Jul; 13(3):239-246. PubMed ID: 29631486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.
    Moorhouse R; Slack C; Quayle M; Essack Z; Lindegger G
    BMC Med Ethics; 2014 Jun; 15():51. PubMed ID: 24981027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychology of "cure" - unique challenges to consent processes in HIV cure research in South Africa.
    Moodley K; Staunton C; Rossouw T; de Roubaix M; Duby Z; Skinner D
    BMC Med Ethics; 2019 Jan; 20(1):9. PubMed ID: 30678664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
    Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
    Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for stakeholder engagement and COVID-19 related clinical trials' conduct in sub-Saharan Africa.
    Folayan MO; Brown B; Haire B; Babalola CP; Ndembi N
    Dev World Bioeth; 2021 Mar; 21(1):44-50. PubMed ID: 32798320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES project.
    Lyerly AD; Beigi R; Bekker LG; Chi BH; Cohn SE; Diallo DD; Eron J; Faden R; Jaffe E; Kashuba A; Kasule M; Krubiner C; Little M; Mfustso-Bengo J; Mofenson L; Mwapasa V; Mworeko L; Myer L; Penazzato M; Rid A; Shapiro R; Singh JA; Sullivan K; Vicari M; Wambui J; White A; Wickremsinhe M; Wolf L
    J Int AIDS Soc; 2021 Dec; 24(12):e25846. PubMed ID: 34910846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From research to international scale-up: stakeholder engagement essential in successful design, evaluation and implementation of paediatric HIV testing intervention.
    Mugo C; Njuguna I; Nduati M; Omondi V; Otieno V; Nyapara F; Mabele E; Moraa H; Sherr K; Inwani I; Maleche-Obimbo E; Wamalwa D; John-Stewart G; Slyker J; Wagner AD
    Health Policy Plan; 2020 Nov; 35(9):1180-1187. PubMed ID: 32944754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key ethical issues encountered during COVID-19 research: a thematic analysis of perspectives from South African research ethics committees.
    Burgess T; Rennie S; Moodley K
    BMC Med Ethics; 2023 Feb; 24(1):11. PubMed ID: 36793067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.